Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Soreghan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|November 18, 1994
Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregationB Soreghan, J Kosmoski, C Glabe
The Journal of Biological Chemistry|December 5, 1990
Organization of the beta-galactoside alpha 2,6-sialyltransferase gene. Evidence for the transcriptional regulation of terminal glycosylationE C Svensson, B Soreghan, J C Paulson
Journal of Physiology, Paris|October 12, 2001
Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathwaysA Tarnawski, I L Szabo, S S Husain, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta proteinM F Knauer, B Soreghan, D Burdick, et al.
Neuroreport|January 14, 1998
Complement activation by cross-linked truncated and chimeric full-length beta-amyloidD H Cribbs, P Velazquez, B Soreghan, et al.
Life Sciences|January 5, 2002
MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growthS S Husain, I L Szabo, R Pai, et al.
Journal of Physiology, Paris|October 12, 2001
NSAIDs inhibit the activation of egr-1 gene in microvascular endothelial cells. A key to inhibition of angiogenesis?I L Szabó, R Pai, B Soreghan, et al.
The Journal of Biological Chemistry|January 5, 1992
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogsD Burdick, B Soreghan, M Kwon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|November 18, 1994
Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregationB Soreghan, J Kosmoski, C Glabe
The Journal of Biological Chemistry|December 5, 1990
Organization of the beta-galactoside alpha 2,6-sialyltransferase gene. Evidence for the transcriptional regulation of terminal glycosylationE C Svensson, B Soreghan, J C Paulson
Journal of Physiology, Paris|October 12, 2001
Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathwaysA Tarnawski, I L Szabo, S S Husain, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta proteinM F Knauer, B Soreghan, D Burdick, et al.
Neuroreport|January 14, 1998
Complement activation by cross-linked truncated and chimeric full-length beta-amyloidD H Cribbs, P Velazquez, B Soreghan, et al.
Life Sciences|January 5, 2002
MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growthS S Husain, I L Szabo, R Pai, et al.
Journal of Physiology, Paris|October 12, 2001
NSAIDs inhibit the activation of egr-1 gene in microvascular endothelial cells. A key to inhibition of angiogenesis?I L Szabó, R Pai, B Soreghan, et al.
The Journal of Biological Chemistry|January 5, 1992
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogsD Burdick, B Soreghan, M Kwon, et al.
Pageof 1